Marianne Dorothy Sadar

USPTO Granted Patents = 18 (Patent Applications = 16)

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 133(Granted Patents)

Company Filing History:

18 out of 932

The University of British Columbia

patents

13 out of 65

British Columbia Cancer Agency Branch

patents

5 out of 23

Provincial Health Services Authority

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109179 - Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof (2024-10-08),

2. 11919874 - Bisphenol derivatives and their use as androgen receptor activity modulators (2024-03-05),

3. 11779550 - Bisphenol ether derivatives and methods for using the same (2023-10-10),

4. 11485713 - Androgen receptor modulators and methods for their use (2022-11-01),

5. 11345670 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2022-05-31),

6. 11142508 - Bisphenol derivatives and their use as androgen receptor activity modulators (2021-10-12),

7. 11059795 - Androgen receptor modulators and methods for their use (2021-07-13),

8. 10654811 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2020-05-19),

9. 10471023 - Bisphenol ether derivatives and methods for using the same (2019-11-12),

10. 10071962 - Androgen receptor modulators and methods for their use (2018-09-11),

11. 9862667 - Diglycidic ether derivative therapeutics and methods for their use (2018-01-09),

12. 9682933 - Androgen receptor modulators and methods for their use (2017-06-20),

13. 9487479 - Small molecule inhibitors of N-terminus activation of the androgen receptor (2016-11-08),

14. 9388112 - Bisphenol derivatives and their use as androgen receptor activity modulators (2016-07-12),

15. 9375496 - Halogenated compounds for cancer imaging and treatment and methods for their use (2016-06-28),

Title: The Innovative Contributions of Marianne Dorothy Sadar

Introduction: Marianne Dorothy Sadar is an acclaimed inventor based in West Vancouver, Canada, known for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 18 patents, she has made strides in developing novel compositions aimed at treating various types of cancer, particularly breast and prostate cancer.

Latest Patents: Among her latest patents, Sadar has developed pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor. This innovation includes a therapeutic regimen that employs an androgen receptor N-terminal domain inhibitor in combination with radiation therapy, targeting malignancies effectively. Additionally, her work on bisphenol derivatives offers potentials as modulators of androgen receptor activity, providing avenues for both therapeutic and diagnostic applications in cancer treatment.

Career Highlights: Marianne has held prominent positions at reputable institutions such as the University of British Columbia and the British Columbia Cancer Agency. Her tenure at these organizations has fostered an environment for advanced research and development in cancer therapeutics, highlighting her dedication to innovative science.

Collaborations: Throughout her career, Marianne has collaborated with notable colleagues, including Raymond John Andersen and Nasrin R Mawji. These partnerships have enriched her research endeavors, leading to impactful advancements in oncology.

Conclusion: Marianne Dorothy Sadar's extensive patent portfolio and her contributions to cancer treatment illustrate her commitment to innovation within the pharmaceutical landscape. Her work not only paves the way for new therapeutic options but also embodies the spirit of collaboration and scientific advancement in addressing critical healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.